US cancer start-up raised its money in Europe but tests its drug in Australia
Actithera, a US start-up developing radiation-based cancer drugs, raised most of its $75.5m from European investors and runs its labs in Oslo. Yet it will treat its first patients in Australia. Its founder Andreas Goutopoulos told EU Perspectives that …